Gertjan Wolbink
- Immunology top 0.2%
- Rheumatology top 0.05%
- Radiology, Nuclear Medicine and Imaging top 0.2%
- Hematology top 0.5%
- Molecular Biology top 5%
- Co-authors
- Theo RispensMichael T. NurmohamedLucien A. AardenBen A. C. DijkmansPauline A. van SchouwenburgSteven O. StapelWillem F. LemsC. Krieckaert
- Topics
- Rheumatoid Arthritis Research and Therapies (92 papers)Monoclonal and Polyclonal Antibodies Research (77 papers)Systemic Lupus Erythematosus Research (62 papers)
- Cited by
- RheumatologyImmunologyHematology
- Partner nations
- NetherlandsUnited StatesSpain
In The Last Decade
Gertjan Wolbink
198 papers receiving 10.6k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Immunology 4.8k
- Rheumatology 4.5k
- Radiology, Nuclear Medicine and Imaging 3.0k
- Hematology 1.5k
- Molecular Biology 1.4k
Countries citing papers authored by Gertjan Wolbink
This map shows the geographic impact of Gertjan Wolbink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gertjan Wolbink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gertjan Wolbink more than expected).
Fields of papers citing papers by Gertjan Wolbink
This network shows the impact of papers produced by Gertjan Wolbink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gertjan Wolbink. The network helps show where Gertjan Wolbink may publish in the future.
Co-authorship network of co-authors of Gertjan Wolbink
This figure shows the co-authorship network connecting the top 25 collaborators of Gertjan Wolbink. A scholar is included among the top collaborators of Gertjan Wolbink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gertjan Wolbink. Gertjan Wolbink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 8 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 16 | |
| 7 | 14 | |
| 8 | 41 | |
| 9 | 1 | |
| 10 | 53 | |
| 11 | 23 | |
| 12 | 46 | |
| 13 | 54 | |
| 14 | 77 | |
| 15 | 54 | |
| 16 | 12 | |
| 17 | 46 | |
| 18 | 22 | |
| 19 | 356 | |
| 20 | 11 |
About Gertjan Wolbink
Gertjan Wolbink is a scholar working on Rheumatology, Immunology and Genetics, having authored 204 papers that have together received 10.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (92 papers), Monoclonal and Polyclonal Antibodies Research (77 papers) and Systemic Lupus Erythematosus Research (62 papers). The work is most often cited by research in Rheumatology (4.5k citations), Immunology (4.8k citations) and Hematology (1.5k citations). Gertjan Wolbink has collaborated with scholars based in Netherlands, United States and Spain. Frequent co-authors include Theo Rispens, Michael T. Nurmohamed, Lucien A. Aarden, Ben A. C. Dijkmans, Pauline A. van Schouwenburg, Steven O. Stapel, Willem F. Lems, C. Krieckaert, G. M. Bartelds and Hans W.M. Niessen. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.